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The aims of this study were to evaluate the prevalence of Dog Erythrocyte Antigens (DEA) 1, 4, and 7 in Ibizan hounds, to
compare the results with the prevalence of DEA in Spanish greyhounds, and to determine the risk of sensitization following the
first transfusion of blood not typed for DEA 1 and the probability of an acute hemolytic reaction following a second incompatible
transfusion using untyped DEA 1 blood. DEA 1, 4, and 7 status was determined in 92 Ibizan hounds. Results were compared with
the previously reported prevalence in Spanish greyhounds. The risks of sensitization and of a hemolytic transfusion reaction were
determined amongst Ibizan hounds and between Ibizan hounds and Spanish greyhounds. The prevalence of DEA 1, 4, and 7 was
75%, 98.9%, and 25%, respectively. There was a significantly higher expression of DEA 1 and 7 in Ibizan hounds than in Spanish
greyhounds. The probability of sensitization of a recipient dog to DEA 1 with transfusions amongst Ibizan hounds was 18.5% and
between Ibizan hounds and Spanish greyhounds was 13.7%.The probability of an acute hemolytic reaction in each group was 3.5%
and 1.9%, respectively. There is a higher prevalence of DEA 1 and 7 in Ibizan hounds than in other sighthounds.
1. Introduction
There is international standardization of seven canine blood
groups as categorized by presence of Dog Erythrocyte Anti-
gen (DEA) 1, 3, 4, 5, 6, 7, and 8 [1]. Other antigen systems
have been reported, such as the recently described Dal blood
type [2], but none of these systems have been standardized.
A donor may express more than one blood group and canine
red blood cells can be negative or positive for any given blood
type [3].
DEA 1 and 7 are the most important blood types with
regard to canine blood transfusions. DEA 1 antigen has
recently been classified as a uniqueDEA epitopewith variable
surface expression (rather than the expression of different
alleles, DEA 1.1, DEA 1.2, and DEA 1.3, as is previously
thought) [4] and is present in approximately half the canine
population [5–11]. There are no naturally occurring anti-
bodies to DEA 1 in dogs. DEA 1 negative dogs exposed to
DEA 1 positive RBCs will become “sensitized” within 9 days
by production of anti-DEA 1 antibodies [12, 13]. Anti-DEA
1 antibodies have been reported to cause acute hemolytic
transfusion reactions in previously sensitized DEA 1 negative
dogs [14].
DEA7 antigens are reported to occur naturally in between
40 and 72% of the canine population [8, 9, 13, 15, 16]. Between
10 and 40% of dogs negative for these antigens have naturally
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occurring antibodies to DEA 7 [3, 17] and delayed RBC
survival is thought to occur in antigen negative dogs receiving
DEA 7 positive blood [15].
There is also a high prevalence of DEA 4 antigens (98–
100%) in the canine population [3, 8, 9, 16] and a hemolytic
transfusion reaction due to DEA 4 alloantibodies has been
reported in a dog [18].
An ideal blood donor does not have blood antigens of
types that commonly cause reactions in unmatched recipi-
ents. There is no universally agreed definition of a universal
canine donor. The most restrictive definition of the universal
canine donorwould be a dog negative forDEA 1, DEA 3,DEA
5, and DEA 7 and positive for DEA 4. Since 98% of dogs are
positive for DEA 4, the rarity of DEA 4 negative dogs means
that this antigen is unlikely to influence donor selection.
Some transfusion specialists do not exclude DEA 7 positive
dogs from the donor pool. In fact the concept of the universal
donor in dogs has long been debated since the tests for DEA 3
and DEA 5 antigens are often not available and the quality of
these tests is variable; currently typing sera are available only
for DEA 1, 4, and 7 antigens. As previously proposed [14],
universal donors are therefore often considered to be dogs
that areDEA 1 and 7 negative. Point-of-care tests are currently
only available forDEA 1, although, in specialized laboratories,
polyclonal antisera are available for DEA 4 andDEA 7 typing.
Ibizan hounds are medium-size sighthounds originating
from the island of Ibiza. They are traditionally used in the
Balearic Islands (and less so in Spain and France) to hunt
rabbits and other small game. In recent times this breed has
been disseminated worldwide through a variety of adoption
programs. The Ibizan hound is classified by the Fe´de´ration
Cynologique Internationale (FCI) in Group 5 (spitz and
primitive types) and in section primitive type-hunting dogs.
This dog is a typical and robust representative of one of
the oldest breeds still in existence (http://www.fci.be/en/
nomenclature/IBIZAN-PODENCO-89.html).
The aims of this study were threefold: (1) to evaluate
the prevalence of DEA 1, DEA 4, and DEA 7 blood type in
Ibizan hounds; (2) to compare the results with the previously
published prevalence of DEAs in other sighthounds (i.e.,
Spanish greyhound); (3) to determine the risk of recipient
sensitization following the first transfusion of blood not
typed for DEA 1 and the probability an acute hemolytic
reaction following a second incompatible transfusion of
blood untyped for DEA 1 both amongst Ibizan hounds and
between Ibizan hounds and Spanish greyhounds.
2. Material and Methods
2.1. Samples. In this prospective study EDTA-anticoagulated
blood samples were collected from 92 healthy owned Ibizan
hounds in January 2015. Dogs were between 1-year and 3-year
old, 89 were female (96.7%) and 3 were male (3.3%), and all
were living on Ibiza Island, Spain.
With the owners’ consent cephalic blood samples were
collected with a 23G needle (Sterican Braun, B. Braun
Melsungen AG, Melsungen, Germany) connected to a
2mL syringe (Injekt Braun, B. Braun Melsungen AG,
Melsungen, Germany). They were transferred to a 1mL
EDTA-anticoagulated tube and were stored between 4 and
5∘C. All blood samples were collected as part of a study to
determine the distribution of blood groups in this breed.
This study was conducted according to European legislation
(2010/63/EU). In all samples blood typing was performed as
described below.
2.2. DEA 1 Blood Typing. DEA 1 status was determined
using a commercially available card agglutination technique
(RapidVet-H, Canine DEA 1.1, Agrolabo SpA, Scarmagno,
Turin, Italy) according to themanufacturer’s instructions and
as previously described [19, 20]. The principle of this card-
based agglutination test is a visible hemagglutination reaction
resulting from the binding of the DEA 1 RBC surface antigen
to a murine monoclonal antibody that is lyophilized on the
card test.
2.3. DEA 4 and DEA 7 Blood Typing. Analysis for DEA 4
and 7 antigens was performed by gel column agglutination
within microtubes (ID-CARD NaCl, Enzyme Test and Cold
Agglutinins, DiaMed, Cressier FR, Switzerland) as previously
described [21] using polyclonal anti-DEA antibodies pro-
duced by Animal Blood Resources International (ABRINT,
Stockbridge, MI, USA).
Anti-DEA 4 and 7 antibodies were imported and used
in this study with the authorization of Italian Health Min-
ister (protocol authorization number 0021278-15/10/2014-
DGSAF-DGSAF-P). Blood-typing was performed at the Vet-
erinary Transfusion Unit (REV) of the University of Milan,
Milan, Italy.
Briefly 25𝜇L of a 0.8% RBC suspension made by sus-
pending 10 𝜇L of the RBC pellet in 1mL of low ionic strength
solution (LISS, ID-DILUENT 2, modified LISS solution,
DiaMed, Cressier FR, Switzerland) was mixed with 25𝜇L of
DEA 7 antibodies or with 15 𝜇L of DEA 4 antibodies in the
reaction chamber of saline gel columns. For all samples a
negative control column with saline solution was included.
The gel columns were incubated at 4∘C for 30 minutes and
were then centrifuged in a special gel column card centrifuge
(ID-CENTRIFUGE 24 S, DiaMed-ID Micro Typing System,
Cressier sur Morat, Switzerland) at 80 × g for 10 minutes.
Finally the gel column cards were evaluated for presence and
strength of agglutination. Only results validated by negative
controls were included in analysis.
The cards were visually interpreted as follows: (0) nega-
tive, when all RBCs were at the bottom of the column; 1+,
when very few RBC agglutinates were dispersed in the lower
part of the gel, with most RBCs at the bottom of the tube;
2+, when all RBCs were agglutinated and dispersed in the gel;
3+, when some RBC agglutinates were dispersed in the upper
part of the gel and most of the RBCs formed a red line on the
surface of the gel; and 4+, when all RBCs formed a red line
on top of the gel. Results were interpreted as negative if no
agglutination or 1+ agglutination was present, whereas ≥2+
agglutination reactions were considered positive.
2.4. Sensitization and Transfusion Risk Analysis for DEA 1.
The probability of an Ibizan hound becoming sensitized
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following the first transfusion of blood that was neither
cross-matched nor typed for DEA 1 was calculated using the
following formula [5, 10]:
[
(% DEA 1 negative ×% DEA 1 positive)
100
] . (1)
The probability of the same dog developing an acute
hemolytic reaction with a second incompatible transfusion
using untyped blood from any other dog was calculated using
the following formula [10]:
[(% DEA 1 negative ×% DEA 1 positive) ×% sensitization for the first transfusion]
10, 000
. (2)
2.5. Statistical Analysis. Results were analysed by absolute
prevalence analysis.Using contingency tables or Fisher’s exact
test the prevalence of DEA 1, 4, and 7 and universal donors in
Ibizan hounds calculated in this study was compared with a
population of 205 Spanish greyhounds (galgo) in which the
prevalence of DEA 1, 4, and 7 and universal donors (i.e., DEA
1 and 7 negative and DEA 4 positive) was 54.6%, 100%, 8%,
and 46.7%, respectively [22].
All statistical analysis was performed using statistical
software (Medcalc software version 14.10.2, Mariakerke, Bel-
gium) with significance set at 𝑃 < 0.05.
3. Results
3.1. DEA 1, DEA 4, and DEA 7 Prevalence. For DEA 1 blood
type, 69 (75%) dogs tested positive and 23 (25%) tested
negative. For DEA 4 blood type, 91 (98.9%) dogs tested
positive (all showed 4+ agglutination) and 1 (1.1%) dog tested
negative. For DEA 7 blood type, 23 (25%) dogs tested positive
(16 samples showed 3+ agglutination and 7 samples showed
2+ agglutination) and 69 (75%) were negative (no samples
showed agglutination). Of the 92 dogs, 16 (17.4%) were DEA 4
positive only (universal donors) and 1 (1.1%) dog was negative
for all DEA. All control samples in the gel columns tested
negative (absence of agglutination).
3.2. Comparison of DEA 1, 4, and 7 Prevalence with Spanish
Greyhounds. Ibizan hounds had a significantly higher preva-
lence ofDEA 1 andDEA7positivity than Spanish greyhounds
(𝑃 = 0.005 and 𝑃 = 0.002, resp.). The prevalence of universal
donors (DEA 1 and DEA 7 negative and DEA 4 positive or
negative) was lower in Ibizan hounds (𝑃 = 0.000008) than in
Spanish greyhounds. There was no significant difference in
DEA 4 prevalence between the 2 breeds.
3.3. Risk of Sensitization for DEA 1 and a Hemolytic Acute
Reaction in an Untyped Recipient. The probability of an
Ibizan hound recipient becoming sensitized following the
first transfusion of blood from an Ibizan hound donor
that was not cross-matched nor typed for DEA 1 was
approximately 1 in 5 (18.8%). The probability of the same
dog developing an acute hemolytic reaction with a second
incompatible transfusion using blood untyped for DEA 1
from any other Ibizan hound was 3.5%.
The probability of a recipient Ibizan hound becoming
sensitized following the first transfusion of blood from a
Spanish greyhound that was not cross-matched nor typed for
DEA 1 was approximately 1 in 7 (13.7%). The probability of
the same dog developing an acute hemolytic reaction with a
second incompatible transfusion using untyped DEA 1 blood
from Spanish greyhound was 1.9%.
4. Discussion
There are breed and geographical differences in the preva-
lence of different blood group antigens [8, 15]. It is essential to
type donor blood in order to select compatible canine blood
donors.The prevalence of positivity to antigens in a potential
donor population can be used to calculate the likelihood that
such an antigen will cause an adverse transfusion reaction
and therefore the risk associated with any transfusion can be
assessed.
In this study the prevalence of DEA 1 expression in Ibizan
hounds was 75%, which is higher than previously reported
in other pure breeds [7–9, 15, 16] and in cross-breed dogs
[6]. The prevalence of DEA 1 in Ibizan hounds was also
much higher than previously reported in other sighthounds,
such as Greyhounds and Spanish greyhounds, in which the
prevalence of DEA 1 has been reported to be 13.1% [16]
and 51.7% [11], respectively. The prevalence of DEA 1 was
statistically significantly higher in Ibizan hounds than in a
population of Spanish greyhounds tested for DEA 1 [22].
All 92 Ibizan hounds were blood typed and only one was
DEA4negative.This prevalence ofDEA4 expression (98.9%)
is in agreement with the prevalence in the general canine
population [6, 7, 9, 16, 21].
The prevalence of DEA 7-positive dogs in the study
population (25%) was similar to that reported in Golden
Retrievers in USA and Brazil (25% and 27% resp.) [7, 9] but
higher than the prevalence reported in cross-breeds (11%)
and German Shepherd dogs (8%) in Brazil [6] and lower
than in Greyhounds in USA (29.1%) [16] and Turkish Kangal
dogs (71.1%) [8]. The prevalence of DEA 7 expression in
Ibizan hounds was statistically significantly higher than in a
population of Spanish greyhounds previously tested by the
authors forDEA 7 [22].These results confirm that as for other
canine blood types, the prevalence of DEA 7 differs between
populations.
The prevalence of universal or “ideal” donors, that is,
dogs positive only for DEA 4 or negative for all DEA, in our
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population of Ibizan hounds, was 18.5%. This is lower than
the prevalence of 57.3% found in greyhounds [16] and in a
population of Spanish greyhounds previously blood typed, in
which prevalence of universal donors was 46.7% [22].
In this study the probability of a recipient becoming
sensitized and produced antibodies against DEA 1 following
the first transfusion of blood that was neither cross-matched
nor typed for DEA 1 was 18.8% (1 in 5) amongst Ibizan
hounds and 13.7% (1 in 7) between Ibizan hounds and Spanish
Greyhounds. These probabilities were lower than previously
reported in dogs from Portugal [10], in Spanish greyhounds
in Spain [11] and in dogs in Brazil [5] in which probabilities
were 24.5%, 22.9%, and 24.9%, respectively. The risk of a
hemolytic transfusion reaction was also lower than the 6%
reported in a previous study [10] since there was a higher
prevalence of DEA 1 positivity in the Ibizan hounds (so these
dogs could receive either DEA 1 negative or DEA 1 positive
blood at first transfusion without transfusion reactions).
The gel agglutination technique has been used for
decades. This test is sensitive for the detection of DEA 1
and is suited for screening blood donors in a blood bank
program [19, 20]. This study used, for only the third time
in the canine blood typing, column gel agglutination with
polyclonal antibodies for DEA 4 and DEA 7 [21, 22]. The
column gel agglutination test is simple to perform, does not
require washing of RBC, requires only small sample and
reagent volumes, and yields results that are simple to read
and stable over time (for up to three days). The study that
validated this technique with polyclonal antibodies for DEA
4 and 7 demonstrated that the test was not 100% sensitive for
identification of DEA 7 [21]. In fact, when gel agglutination
was compared with tube agglutination (considered the gold
standard), there were 12 discordant results for DEA 7 (con-
cordance of 84%). The gel agglutination test had a specificity
of 100% and a sensitivity of 53% for identification of the DEA
7 positive samples when compared with tube agglutination
[21]. This may represent a limitation of our study as the true
prevalence of DEA 7 positive dogsmay have been higher than
detected using this test.
Another limitation of this study was that the study
population of Ibizan hounds was almost exclusively female,
mirroring the environment in which Ibizan hounds live.
Hunters run these dogs in mostly female packs, as the female
is considered the better hunter. In addition we did not know
how closely related the dogs used in this study were. It is
possible that a closed population of closely related individuals
could bias the prevalence of blood types. Finally DEA 3, DEA
5, and Dal blood types were not tested since relevant antisera
were unavailable at the time the study was performed.
5. Conclusion
The population of Ibizan hounds studied here showed a
different prevalence for DEA 1 and 7 with respect to previous
reports of other sighthounds. Although the risk of sensitiza-
tion and an acute transfusion reaction following incompatible
blood transfusion is low, it remains best practice to blood type
and cross-match recipients before transfusion.
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